- Zepp Health (ZEPP, Financial) reported a minor GAAP loss of $0.06 per share in Q1.
- Company revenue decreased slightly by 3.3% year-over-year, totalling $38.5 million.
- Despite challenges, Zepp Health maintains a strong cash reserve of $104 million after settling short-term debt.
Zepp Health (ZEPP) experienced a challenging first quarter, posting a GAAP loss of $0.06 per share. The company's revenue saw a slight decline, settling at $38.5 million, representing a 3.3% decrease compared to the same period last year. Despite this, the company's gross margin showed a modest improvement to 37.3%. Notably, Zepp Health has managed to maintain healthy cash reserves of $104 million even after repaying $11.5 million in short-term debt.
Wall Street Analysts Forecast
According to one analyst's one-year price targets, Zepp Health Corp (ZEPP, Financial) is expected to reach an average price target of $13.87. This target is consistent across high and low estimates, suggesting a significant potential upside of 388.28% from the current trading price of $2.84. Investors looking for more detailed estimates can visit the Zepp Health Corp (ZEPP) Forecast page.
The current consensus recommendation from one brokerage firm indicates an "Outperform" status for Zepp Health Corp (ZEPP, Financial), with an average brokerage recommendation of 2.0. The rating scale used ranges from 1 (Strong Buy) to 5 (Sell), highlighting a positive outlook from analysts.
In contrast, according to GuruFocus estimates, the estimated GF Value for Zepp Health Corp (ZEPP, Financial) over the next year is $2.11. This suggests a potential downside of 25.7% from the current share price of $2.84. The GF Value represents GuruFocus' estimation of the stock's fair trading value, derived from historical trading multiples and projected business performance. For an in-depth analysis, visit the Zepp Health Corp (ZEPP) Summary page.
